SXL
SER icon

Summit X LLC’s Serina Therapeutics SER Stock Holding History

Summit X LLC’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-640
Closed -$8.66K – 217
2023
Q4 		$8.66K Sell
640
-412
-39% -$7.58K ﹤0.01% 190
2023
Q3 		$25.2K Buy
1,052
+341
+48% +$9.02K 0.01% 179
2023
Q2 		$22.3K Sell
711
-213
-23% -$4.56K 0.01% 268
2023
Q1 		$21.5K Sell
924
-14
-1% -$322 0.01% 260
2022
Q4 		$19K Buy
938
+14
+2% +$295 0.01% 239
2022
Q3 		$18K Sell
924
-14
-1% -$317 0.01% 244
2022
Q2 		$19K Hold
938
– – 0.01% 241
2022
Q1 		$28K Buy
938
+213
+29% +$6.06K 0.01% 251
2021
Q4 		$28K Buy
725
+142
+24% +$3.84K 0.01% 255
2021
Q3 		$19K Hold
583
– – ﹤0.01% 259
2021
Q2 		$32K Hold
583
– – 0.01% 260
2021
Q1 		$33K Buy
583
+142
+32% +$9.94K 0.01% 257
2020
Q4 		$24K Sell
441
-227
-34% -$13.1K 0.01% 245
2020
Q3 		$2 Buy
668
+170
+34% +$6.07K ﹤0.01% 441
2020
Q2 		$17K Buy
+498
New +$14.7K 0.01% 209

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $486M AUM 59.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.55B AUM 19.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Summit X LLC's SER Position: Q1 2024 in Review

Summit X LLC sold out of Serina Therapeutics (SER) in Q1 2024, closing a stake of 640 shares — an estimated $8.66K sold.

Summit X LLC first reported a position in SER in Q2 2020 and held it in 15 quarters. The position peaked at $33K in Q1 2021. 13 funds tracked by Wall St. Rank hold SER as of Q1 2024.

  • Summit X LLC reported no remaining Serina Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Summit X LLC sold 640 Serina Therapeutics shares in Q1 2024, an estimated $8.66K.
  • Summit X LLC first reported a position in Serina Therapeutics in Q2 2020 and held it in 15 quarters.
  • Summit X LLC's Serina Therapeutics position peaked at $33K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2024.

Based on Summit X LLC's 13F filing for Q1 2024, filed 8 May 2024.